Hematology & Oncology Open Select

Are you thinking about publishing your hematology or oncology research open access? Do you realise you’re not restricted to only publishing in one of our fully open journals? We also offer an Open Select hybrid model for the majority of our journals, including Leukemia & Lymphoma and Hemoglobin, enabling you to publish open access in what is traditionally a subscription journal. Find out more about Open Select and the journals that offer this option.

Scroll down to peruse the articles previously published through our Open Select programme across our hematology and oncology portfolio. If you publish your article through this programme you could see your paper here too!

• 2017
• 2016
• Archive

2017

• *NEW* Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden

  • Acta Oncologica
  • Katarina Tomic, Marcus Westerberg, David Robinson, Hans Garmo & Pär Stattin

• *NEW* Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets

  • Cancer Biology & Therapy
  • Wenchu Lin et al.

• *NEW* TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells

  • Cancer Biology & Therapy
  • Jeffrey Q. Nguyen & Rosalyn B. Irby

• *NEW* Fc-mediated activity of EGFR x c-Met bispecific antibody JNJ-61186372 enhanced killing of lung cancer cells

  • mAbs
  • Katharine D. Grugan et al.

• *NEW* Complementing genomics and transcriptomics: Phosphoproteomics illuminates systems biology in prostate cancer

  • Molecular & Cellular Oncology
  • Victor M. Tan, Larry C. Cheng & Justin M. Drake

• *NEW* Relevance of epithelial-to-pericyte transition in cancer

  • Molecular & Cellular Oncology
  • Anitha K. Shenoy & Jianrong Lu

• *NEW* Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk

  • OncoImmunology
  • Elise P. Salerno et al.

• *NEW* T-cell-expressed proprotein convertase FURIN inhibits DMBA/TPA-induced skin cancer development

  • OncoImmunology
  • Maria Vähätupa et al.

• *NEW* Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer

  • OncoImmunology
  • Mehrdad Talebian Yazdi et al.

• *NEW* The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome

  • OncoImmunology
  • Roberta Melchionna et al.

• *NEW* Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma

  • OncoImmunology
  • Alejandra Leivas et al.

• *NEW* Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity

  • OncoImmunology
  • Xiao Hu et al.

• *NEW* CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside

  • OncoImmunology
  • Qi Zhang, Zimu Zhang, Meiyu Peng, Shuyu Fu, Zhenyi Xue & Rongxin Zhang

• *NEW* Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy

  • OncoImmunology
  • Henoch S. Hong et al.

• *NEW* CD40L confers helper functions to human intra-melanoma class-I-restricted CD4CD8 double positive T cells

  • OncoImmunology
  • Tiphaine Parrot et al.

• *NEW* The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome

  • OncoImmunology
  • Lotte Pyfferoen et al.

• *NEW* Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer

  • OncoImmunology
  • Sean G. Smith et al.

2016

• Abscopal effect of radiotherapy in a patient with metastatic diffuse-type giant cell tumor

  • Acta Oncologica
  • Ingrid M. E. Desar et al.

• Accuracy requirements and uncertainties in radiotherapy: a report of the International Atomic Energy Agency

  • Acta Oncologica
  • Debbie van der Merwe et al.

• Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemia

  • Leukemia and Lymphoma
  • Norbert Vey et al.

• Targeting histone deacetylases in T-cell lymphoma

  • Leukemia and Lymphoma
  • Alison J. Moskowitz & Steven M. Horwitz

• Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma

  • OncoImmunology
  • Zheng Wang et al.

• Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma

  • OncoImmunology
  • Shiro Suzuki et al.

• An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi

  • Cancer Biology & Therapy
  • Keita Mizuno, Keisuke Shibata, Ryohei Komatsu, Yuji Omiya, Yoshio Kase & Schuichi Koizumi

• Rapid tumor regression in an Asian lung cancer patient following personalized neo-epitope peptide vaccination

  • OncoImmunology
  • Fenge Li et al.

• Hypoxia and antitumor CD8 T cells: An incompatible alliance?

  • OncoImmunology
  • Romain Vuillefroy de Silly, Pierre-Yves Dietrich & Paul R. Walker

• Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma

  • OncoImmunology
  • Marcel A. Deken et al.

• Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry

  • Acta Oncologica
  • Bradford S. Hoppe et al.

• Investigator and independent review committee exploratory assessment and verification of tumor response in a non-Hodgkin lymphoma study

  • Leukemia and Lymphoma
  • Robert R. Ford, Robert W. Ford, Michael O’Neal, Brad S. Kahl, Ling Chen, Mihaela Munteanu & Bruce D. Cheson

• RIG-I activation induces the release of extracellular vesicles with antitumor activity

  • OncoImmunology
  • Juliane Daßler-Plenker et al.

• Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition

  • OncoImmunology
  • Patricia Kleinpeter et al.

• GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity

  • OncoImmunology
  • Michael S. Magee et al.

• Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb

  • Cancer Biology & Therapy
  • Jacklynn V. Egger, Maria V. Lane, Lisa A. Antonucci, Brixhilda Dedi & Nancy A. Krucher

• Novel anti-EPHA2 antibody, DS-8895a for cancer treatment

  • Cancer Biology & Therapy
  • Jun Hasegawa et al.

• The actin binding proteins cortactin and HS1 are dispensable for platelet actin nodule and megakaryocyte podosome formation

  • Platelets
  • Steven G. Thomas, Natalie S. Poulter, Danai Bem, Brenda Finney, Laura M. Machesky & Stephen P. Watson

• The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostat

  • OncoImmunology
  • Yusuke Tomita et al.

• microRNA-155 deficiency impairs dendritic cell function in breast cancer

  • OncoImmunology
  • Junfeng Wang et al.

• Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients

  • Acta Oncologica
  • Particia Holch et al.

• The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines

  • Cancer Biology & Therapy
  • Maria Cosenza, Monica Civallero, Stefania Fiorcari, Samantha Pozzi, Luigi Marcheselli, Alessia Bari, Paola Ferri & Stefano Sacchi

• Exosomes secreted from human colon cancer cells influence the adhesion of neighboring metastatic cells: Role of microRNA-210

  • Cancer Biology & Therapy
  • Elisabetta Bigagli, Cristina Luceri, Daniele Guasti & Lorenzo Cinci

• Downregulation of a novel human gene, ROGDI, increases radiosensitivity in cervical cancer cells

  • Cancer Biology & Therapy
  • Yi-Fan Chen, Jonathan J. Cho, Tsai-Hua Huang, Chao-Neng Tseng, Eng-Yen Huang & Chung-Lung Cho

• The significance of FOXP1 in diffuse large B-cell lymphoma

  • Leukemia and Lymphoma
  • Duncan M. Gascoyne & Alison H. Banham

• Therapeutic targets and new directions for antibodies developed for ovarian cancer

  • mAbs
  • Heather J. Bax, Debra H. Josephs, Giulia Pellizzari, James F. Spicer, Ana Montes & Sophia N. Karagiannis

• Two different “tales” of ATG7: Clinical relevance to myelodysplastic syndromes

  • Molecular & Cellular Oncology
  • Abdullah M. Ali & Azra Raza

• Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway

  • OncoImmunology
  • Emilie Duvallet et al.

• Melanomas prevent endothelial cell death under restrictive culture conditions by signaling through AKT and p38 MAPK/ ERK-1/2 cascades

  • OncoImmunology
  • Asha M. Das et al.

• An investigation of the antiplatelet effects of succinobucol (AGI-1067)

  • Platelets
  • Stephanie A. Houston, Azizah Ugusman, Sukanya Gnanadesikan & Simon Kennedy

• Distinct mechanisms of B and T lymphocyte accumulation generate tumor-draining lymph node hypertrophy

  • OncoImmunology
  • Lauren M. Habenicht, Tina C. Albershardt, Brian M. Iritani & Alanna Ruddell

• Targeting CD73 in the tumor microenvironment with MEDI9447

  • OncoImmunology
  • Carl M. Hay et al.

• Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

  • OncoImmunology
  • Steve Boudewijns et al.

• CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors

  • OncoImmunology
  • Marina Bacac, Christian Klein & Pablo Umana

• Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma

  • OncoImmunology
  • Hiroyuki Inoue et al.

• Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome

  • OncoImmunology
  • Linan Wang et al.

• NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway

  • Cancer Biology & Therapy
  • Runna Ai et al.

• BORA-dependent PLK1 regulation: A new weapon for cancer therapy?

  • Molecular & Cellular Oncology
  • Luca Cirillo, Yann Thomas, Lionel Pintard & Monica Gotta

• Analysis of circulating tumor cells in colorectal cancer liver metastasis patients before and after cryosurgery

  • Cancer Biology & Therapy
  • Jian Shi et al.

• Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia

  • Leukemia and Lymphoma
  • Michael J. Burke & Susan R. Rheingold

• Rationale and motivating factors for treatment-free remission in chronic myeloid leukemia

  • Leukemia and Lymphoma
  • Lauren Caldemeyer & Luke P. Akard

• [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice

  • Leukemia and Lymphoma
  • Ida Wong-Sefidan et al.

• Ruxolitinib is effective in patients with intermediate-1 risk myelofibrosis: a summary of recent evidence

  • Leukemia and Lymphoma
  • Claire N. Harrison, Moshe Talpaz & Adam J. Mead

• Use of class I histone deacetylase inhibitor romidepsin in combination regimens

  • Leukemia and Lymphoma
  • Adam Petrich & Chadi Nabhan

• Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices

  • Leukemia and Lymphoma
  • Ranjana Arora & Richard D. Press

• Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials

  • Leukemia and Lymphoma
  • David S. Siegel et al.

• Insulin glargine use and breast cancer risk: Associations with cumulative exposure

  • Acta Oncologica
  • Paul J. H. L. Peeters et al.

• Sperm preservation and neutron contamination following proton therapy for prostate cancer study

  • Acta Oncologica
  • Bradford S. Hoppe et al.

• Assessing in vivo dynamics of multiple quality attributes from a therapeutic IgG4 monoclonal antibody circulating in cynomolgus monkey

  • mAbs
  • Yinyin Li et al.

• Suppression of pancreatic ductal adenocarcinoma growth by intratumoral delivery of attenuated Salmonella typhimurium using a dual fluorescent live tracking system

  • Cancer Biology & Therapy
  • Sujin Zhou, Zhenggang Zhao, Yan Lin, Sijia Gong, Fanghong Li, Jinshun Pan, Xiaoxi Li, Zhuo Gao & Allan Z. Zhao

• Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence

  • Cancer Biology & Therapy
  • Muhammad Bilal Abid, Sanjay De Mel, Muhammad Abbas Abid, Kong Bing Tan & Wee Joo Chng

• Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma

  • Expert Review of Molecular Diagnostics
  • Ravi Salgia

• The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study

  • Leukemia and Lymphoma
  • Pier Luigi Zinzani et al.

• Relationship of response and survival in patients with relapsed and refractory multiple myeloma treated with pomalidomide plus low-dose dexamethasone in the MM-003 trial randomized phase III trial (NIMBUS)

  • Leukemia and Lymphoma
  • Philippe Moreau et al.

• A novel small-molecule inhibitor of 3-phosphoglycerate dehydrogenase

  • Molecular & Cellular Oncology
  • Edouard Mullarky, Luke L. Lairson, Lewis C. Cantley & Costas A. Lyssiotis

• Mutational landscape and underlying mutational processes in chronic lymphocytic leukemia

  • Molecular & Cellular Oncology
  • S. Kasar & J. R. Brown

• Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

  • OncoImmunology
  • Yu Sawada et al.

• The clinical impact of ICOS signal in colorectal cancer patients

  • OncoImmunology
  • Yan Zhang, Yang Luo, Shao-Lan Qin, Yi-Fei Mu, Yang Qi, Min-Hao Yu & Ming Zhong

• Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma

  • OncoImmunology
  • Ioannis Karydis, Pui Ying Chan, Matthew Wheater, Edurne Arriola, Peter W. Szlosarek & Christian H. Ottensmeier

• The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder

  • OncoImmunology
  • Alexander S. Baras et al.

• ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing

  • OncoImmunology
  • Maria Raffaella Zocchi et al.

• Motolimod effectively drives immune activation in advanced cancer patients

  • OncoImmunology
  • Gregory N. Dietsch

• Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis

  • OncoImmunology
  • Bodo E. Lippitz & Robert A. Harris

• Thymic hyperplasia after chemotherapy in adults with mature B cell lymphoma and its influence on thymic output and CD4+ T cells repopulation

  • OncoImmunology
  • Dao-Ping Sun, Hui Jin, Chong-Yang Ding, Jin-Hua Liang, Li Wang, Lei Fan, Yu-Jie Wu, Wei Xu & Jian-Yong Li

• Reducing prostaglandin E2 production to raise cancer immunogenicity

  • OncoImmunology
  • Santiago Zelenay & Caetano Reis e Sousa

• Combined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosis

  • OncoImmunology
  • Monika Dadrich et al.

• Cripto-1 vaccination elicits protective immunity against metastatic melanoma

  • OncoImmunology
  • M. A. Ligtenberg, K. Witt, F. Galvez-Cancino, A. Sette, A. Lundqvist, A. Lladser & R. Kiessling

• (Compl)Ex-Th17–Treg cell inter-relationship

  • OncoImmunology
  • Nataša Obermajer & Marc H Dahlke

• Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer

  • OncoImmunology
  • Jessica Nakhlé et al.

• An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs

  • OncoImmunology
  • Masatoshi Hirayama et al.

• A Tec kinase BTK inhibitor ibrutinib promotes maturation and activation of dendritic cells

  • OncoImmunology
  • Gayathri Natarajan, Steve Oghumu, Cesar Terrazas, Sanjay Varikuti, John C. Byrd & Abhay R. Satoskar

• NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8+ T lymphocytes

  • OncoImmunology
  • Galaxia M. Rodriguez et al.

• The accuracy of preoperative axillary nodal staging in primary breast cancer by ultrasound is modified by nodal metastatic load and tumor biology

  • Acta Oncologica
  • Looket Dihge, Dorthe A. Grabau, Rogvi W. Rasmussen, Pär-Ola Bendahl & Lisa Rydén

• Identifying cancer origin using circulating tumor cells

  • Cancer Biology & Therapy
  • Si-Hong Lu et al.

• Ganetespib radiosensitization for liver cancer therapy

  • Cancer Biology & Therapy
  • Sivarajan T. Chettiar et al.

• Pluripotency markers are differentially induced by MEK inhibition in thyroid and melanoma BRAFV600E cell lines

  • Cancer Biology & Therapy
  • Emma R. Dorris et al.

• A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation

  • Leukemia and Lymphoma
  • Katja Weisel et al.

• Length-independent structural similarities enrich the antibody CDR canonical class model

  • mAbs
  • Jaroslaw Nowak et al.

• Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors

  • mAbs
  • Silvia Calpe, Ana C. P. Correia, Maria del Carmen Sancho-Serra & Kausilia K. Krishnadath

• Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity

  • mAbs
  • Andrew D. Tustian, Christine Endicott, Benjamin Adams, John Mattila & Hanne Bak

• XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer

  • mAbs
  • Juergen M. Schanzer et al.

• Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates

  • mAbs
  • Heather Donaghy

• Linking apoptosis to cancer metabolism: Another missing piece of JuNK

  • Molecular & Cellular Oncology
  • Salvatore Papa & Concetta Bubici

• The BARD1/HP1 interaction: Another clue to heterochromatin involvement in homologous recombination

  • Molecular & Cellular Oncology
  • Takayo Fukuda, Tomoko Tsuruga, Takako Kuroda, Jun Takeuchi, Wenwen Wu & Tomohiko Ohta

• Differentiation therapy for glioblastoma – too many obstacles?

  • Molecular & Cellular Oncology
  • Helena Carén, Stephan Beck & Steven M. Pollard

• Reactive oxygen species and tumor dissemination: Allies no longer

  • Molecular & Cellular Oncology
  • Cecilia Herraiz, Eva Crosas-Molist & Victoria Sanz-Moreno

• Mirror image phosphoinositides regulate autophagy

  • Molecular & Cellular Oncology
  • Mariella Vicinanza & David C Rubinsztein

• Regulation of the centrosome cycle

  • Molecular & Cellular Oncology
  • Hiroki Fujita, Yuki Yoshino & Natsuko Chiba

• EglN2 positively regulates mitochondrial function in breast cancer

  • Molecular & Cellular Oncology
  • Jing Zhang, Xingnan Zheng & Qing Zhang

• Antitumor activity of LSD1 inhibitors in lung cancer

  • Molecular & Cellular Oncology
  • Helai P. Mohammad & Ryan G. Kruger

• EnABLing microprocessor for apoptosis

  • Molecular & Cellular Oncology
  • Chi-Chiang Tu & Jean Y. J. Wang

• USP11: A key regulator of cIAP2 stability and sensitivity to SMAC mimetics

  • Molecular & Cellular Oncology
  • Eun-Woo Lee & Jaewhan Song

• A TAD closer to ATM

  • Molecular & Cellular Oncology
  • Francois Aymard & Gaëlle Legube

• BMP2, a key to uncover luminal breast cancer origin linked to pollutant effects on epithelial stem cells niche

  • Molecular & Cellular Oncology
  • Marion Chapellier & Véronique Maguer-Satta

• News and views on EMT Fra-1 controls EMT in mammary epithelial cells

  • Molecular & Cellular Oncology
  • Latifa Bakiri & Erwin F. Wagner

• Pinched by RNA “fingers”: Long noncoding RNAs hitting signal transduction pathways

  • Molecular & Cellular Oncology
  • Bodu Liu, Lijuan Sun & Erwei Song

• Spatiotemporal plasticity of miRNAs functions: The miR-17-92 case

  • Molecular & Cellular Oncology
  • Tiziana Bonaldi & Marija Mihailovich

• Tumor suppression by stromal TIMPs

  • Molecular & Cellular Oncology
  • Masayuki Shimoda, Hartland W. Jackson & Rama Khokha

• The paradox of dicer in cancer

  • Molecular & Cellular Oncology
  • Vijay Swahari, Ayumi Nakamura & Mohanish Deshmukh

• Advances in clinical NK cell studies: Donor selection, manufacturing and quality control

  • OncoImmunology
  • U. Koehl et al.

Archive

• Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update

  • Leukemia and Lymphoma
  • Bruce D. Cheson et al.

• Multi-Site N-glycan mapping study 1: Capillary electrophoresis - laser induced fluorescence

  • mAbs
  • Ákos Szekrényes et al.

• Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting

  • mAbs
  • Saskia Meyer et al.

• Generation and preclinical characterization of an antibody specific for SEMA4D

  • mAbs
  • Terrence L. Fisher et al.

• Point mutations in the tumor suppressor Smad4/DPC4 enhance its phosphorylation by GSK3 and reversibly inactivate TGF-β signaling

  • Molecular & Cellular Oncology
  • Hadrien Demagny & Edward M De Robertis

• A five-factor biomarker profile obtained week 4 - of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2

  • Acta Oncologica
  • Anne V. Soerensen et al.

• Incidence and management of myelosuppression in patients with chronic- and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate

  • Leukemia and Lymphoma
  • Luke Akard et al.

• Asparaginase-associated toxicity in children with acute lymphoblastic leukemia

  • Leukemia and Lymphoma
  • Nobuko Hijiya & Inge M. van der Sluis

• Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases

  • mAbs
  • Michela Silacci et al.

• The European antibody network's practical guide to finding and validating suitable antibodies for research

  • mAbs
  • Giovanna Roncador et al.

• Mechanisms of innate immunity in C. elegans epidermis

  • Tissue Barriers
  • Clara Taffoni & Nathalie Pujol

• Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer

  • Acta Oncologica
  • Jacob Elebro et al.

• Pixantrone induces cell death through mitotic perturbations and subsequent aberrant cell divisions

  • Cancer Biology & Therapy
  • Neil Beeharry, Andrea Ghelli Luserna Di Rora, Mitchell R Smith & Timothy J Yen

• Small molecule inhibitors of IRES-mediated translation

  • Cancer Biology & Therapy
  • Christos Vaklavas et al.

• Identification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy

  • Cancer Biology & Therapy
  • Liming Wang et al.

• Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51

  • Cancer Biology & Therapy
  • Bingliang Wang et al.

• ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer

  • Expert Review of Anticancer Therapy
  • Karim Fizazi, Laurence Albiges, Yohann Loriot & Christophe Massard et al.

• Bendamustine reactivates latent Epstein-Barr virus

  • Leukemia and Lymphoma
  • Samantha G. Fernandez & JJ L. Miranda

• Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling

  • Molecular & Cellular Oncology
  • Hadrien Demagny & Edward M De Robertis

• The role of platelets in the recruitment of leukocytes during vascular disease

  • Platelets
  • G. Ed Rainger et al.

• Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles

  • Platelets
  • Virginia M. Miller et al.

• Asparaginase pharmacokinetics and implications of therapeutic drug monitoring

  • Leukemia and Lymphoma
  • Barbara Asselin & Carmelo Rizzari

• Multi-functionality and plasticity characterize epithelial cells in Hydra

  • Tissue Barriers
  • W Buzgariu, S Al Haddad, S Tomczyk, Y Wenger & B Galliot

• Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis

  • Leukemia and Lymphoma
  • Chul Won Jung et al.

• Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis

  • Leukemia and Lymphoma
  • Chul Won Jung et al.

• VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions

  • Leukemia and Lymphoma
  • Elisabeth Hinterseer et al.

• VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions

  • Leukemia and Lymphoma
  • Elisabeth Hinterseer et al.

• Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation

  • Leukemia and Lymphoma
  • Fariba Fouladi et al.

• Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation

  • Leukemia and Lymphoma
  • Fariba Fouladi et al.

• Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages

  • Cancer Biology & Therapy
  • Judy Choi, Beate Stradmann-Bellinghausen, Eduard Yakubov, Nicolai E Savaskan & Anne Régnier-Vigouroux

• Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages

  • Cancer Biology & Therapy
  • Judy Choi, Beate Stradmann-Bellinghausen, Eduard Yakubov, Nicolai E Savaskan & Anne Régnier-Vigouroux

• The other face of TLR3: A driving force of breast cancer stem cells

  • Molecular & Cellular Oncology
  • Deyong Jia & Lisheng Wang

• The other face of TLR3: A driving force of breast cancer stem cells

  • Molecular & Cellular Oncology
  • Deyong Jia & Lisheng Wang

• Context-dependent utilization of serine in cancer

  • Molecular & Cellular Oncology
  • Mahya Mehrmohamadi & Jason W Locasale

• Context-dependent utilization of serine in cancer

  • Molecular & Cellular Oncology
  • Mahya Mehrmohamadi & Jason W Locasale

• Genomic instability establishes dependencies on acquired gene regulatory networks: A novel role of p62 in myeloid malignancies with del(5q)

  • Molecular & Cellular Oncology
  • Jing Fang & Daniel T Starczynowski

• Genomic instability establishes dependencies on acquired gene regulatory networks: A novel role of p62 in myeloid malignancies with del(5q)

  • Molecular & Cellular Oncology
  • Jing Fang & Daniel T Starczynowski

• MKP1 mediates resistance to therapy in HER2-positive breast tumors

  • Molecular & Cellular Oncology
  • Demet Candas & Jian Jian Li

• MKP1 mediates resistance to therapy in HER2-positive breast tumors

  • Molecular & Cellular Oncology
  • Demet Candas & Jian Jian Li

• (-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization

  • Molecular & Cellular Oncology
  • Onica LeGendre, Paul AS Breslin & David A Foster

• (-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization

  • Molecular & Cellular Oncology
  • Onica LeGendre, Paul AS Breslin & David A Foster

• p85α neomorphic mutants: splitting away from the canonical path

  • Molecular & Cellular Oncology
  • Lydia WT Cheung & Gordon B Mills

• p85α neomorphic mutants: splitting away from the canonical path

  • Molecular & Cellular Oncology
  • Lydia WT Cheung & Gordon B Mills

• HIF-1 suppresses lipid catabolism to promote cancer progression

  • Molecular & Cellular Oncology
  • Huafeng Zhang

• HIF-1 suppresses lipid catabolism to promote cancer progression

  • Molecular & Cellular Oncology
  • Huafeng Zhang

• Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers

  • Molecular & Cellular Oncology
  • Thierry Lebret, Yann Neuzillet, Nadine Houede, Sandra Rebouissou, Isabelle Bernard-Pierrot, Aurélien De Reynies, Simone Benhamou, Yves Allory & François Radvanyi

• Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers

  • Molecular & Cellular Oncology
  • Thierry Lebret, Yann Neuzillet, Nadine Houede, Sandra Rebouissou, Isabelle Bernard-Pierrot, Aurélien De Reynies, Simone Benhamou, Yves Allory & François Radvanyi

• Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinoma

  • OncoImmunology
  • Peter Duewell et al.

• Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinoma

  • OncoImmunology
  • Peter Duewell et al.

• A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development

  • OncoImmunology
  • Oana Draghiciu, Annemarie Boerma, Baukje Nynke Hoogeboom, Hans W Nijman & Toos Daemen

• A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development

  • OncoImmunology
  • Oana Draghiciu, Annemarie Boerma, Baukje Nynke Hoogeboom, Hans W Nijman & Toos Daemen

• A novel actor in antitumoral immunity: The thymus-specific serine protease TSSP/PRSS16 involved in CD4+ T-cell maturation

  • OncoImmunology
  • Lydie Brisson & Alice Carrier

• A novel actor in antitumoral immunity: The thymus-specific serine protease TSSP/PRSS16 involved in CD4+ T-cell maturation

  • OncoImmunology
  • Lydie Brisson & Alice Carrier

• IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer

  • OncoImmunology
  • Serena Lunardi, Su Yin Lim, Ruth J Muschel & Thomas B Brunner

• IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer

  • OncoImmunology
  • Serena Lunardi, Su Yin Lim, Ruth J Muschel & Thomas B Brunner

• BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties

  • OncoImmunology
  • Cara L Haymaker et al.

• BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties

  • OncoImmunology
  • Cara L Haymaker et al.

• Long-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2

  • OncoImmunology
  • Nicolle H Rekers, Catharina ML Zegers, Wilfred TV Germeraad, Ludwig Dubois & Philippe Lambin

• Long-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2

  • OncoImmunology
  • Nicolle H Rekers, Catharina ML Zegers, Wilfred TV Germeraad, Ludwig Dubois & Philippe Lambin

• Several immune escape patterns in non-Hodgkin's lymphomas

  • OncoImmunology
  • Camille Laurent et al.

• Several immune escape patterns in non-Hodgkin's lymphomas

  • OncoImmunology
  • Camille Laurent et al.

• Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy

  • OncoImmunology
  • Heleen H Van Acker, Sébastien Anguille, Viggo F Van Tendeloo & Eva Lion

• Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy

  • OncoImmunology
  • Heleen H Van Acker, Sébastien Anguille, Viggo F Van Tendeloo & Eva Lion

• Dynamic analysis of platelet deposition to resolve platelet adhesion receptor activity in whole blood at arterial shear rate

  • Platelets
  • Nicholas Pugh, Dominique Bihan, David J. Perry & Richard W. Farndale

• Dynamic analysis of platelet deposition to resolve platelet adhesion receptor activity in whole blood at arterial shear rate

  • Platelets
  • Nicholas Pugh, Dominique Bihan, David J. Perry & Richard W. Farndale

• Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function

  • Platelets
  • Abdimajid Osma et al.

• Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function

  • Platelets
  • Abdimajid Osma et al.

• Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?

  • Expert Review of Molecular Diagnostics
  • Sinuhe Hahn, Olav Lapaire & Nandor Gabor Than

• Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients

  • OncoImmunology
  • Kalijn F Bol et al.

• Depletion of B220+NK1.1+ cells enhances the rejection of established melanoma by tumor-specific CD4+ T cells

  • OncoImmunology
  • Kyle A Wilson, Stephen R Goding, Harold R Neely, Kristina M Harris & Paul Andrew Antony

• Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma

  • OncoImmunology
  • Travis E Grotz et al.

• Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients

  • OncoImmunology
  • Neil L Berinstein et al.

• Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies

  • OncoImmunology
  • Tana Omokoko, Petra Simon, Özlem Türeci & Ugur Sahin

• Restoration of natural killer activity in hepatocellular carcinoma by treatment with antibody against granulin-epithelin precursor

  • OncoImmunology
  • Phyllis FY Cheung et al.

• Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation

  • OncoImmunology
  • Tomomi Toubai et al.

• Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen

  • OncoImmunology
  • Jenette Creaney et al. 

• Kick-starting the cancer-immunity cycle by targeting CD40

  • OncoImmunology
  • P Ellmark, S M Mangsbo, C Furebring, T H Tötterman & P Norlén

• Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+ T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer

  • OncoImmunology
  • L Vassilev et al.

• Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy

  • OncoImmunology
  • Nicola Mozzillo et al.